Gene-Environment Interactions in Glaucoma

青光眼的基因与环境相互作用

• 批准号: 8830454
• 负责人: Louis Robert Pasquale
• 金额: $ 44.6万
• 依托单位: MASSACHUSETTS EYE AND EAR INFIRMARY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2018-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8830454
• 关键词: Age; Aging; Anthocyanins; Berry; Bioflavonoid; Biological Markers; Blindness; CAV1 gene; CAV2 gene; Caveolins; Cell membrane; Cell physiology; Clinical; Clinical Trials; Code; Cohort Analysis; Collaborations; Communication; Complex; Data; Databases; Diet; Dietary Flavonoid; Disease; Drug Targeting; ESR1 gene; ESR2 gene; Endothelial Cells; Environmental Risk Factor; Estradiol; Estrogen Metabolism; Estrogen Receptors; Estrogens; Estrone; Flavonoids; Food; Functional disorder; GUCY1A3 gene; GUCY1B3 gene; Genetic; Genetic Markers; Genetic Predisposition to Disease; Genetic Risk; Genotype; Glaucoma; Goals; Gonadal Steroid Hormones; Health Professional; Hormone use; Human Genetics; Hypertension; Intake; Internet; Lead; Mediating; Menopause; Metabolic Pathway; Metabolism; Modeling; National Eye Institute; Nitric Oxide; Nitric Oxide Synthase; Non-Insulin-Dependent Diabetes Mellitus; Nurses' Health Study; Optic Nerve; Pathology; Patients; Peripheral; Physiologic Intraocular Pressure; Postmenopause; Prevention strategy; Preventive Intervention; Primary Open Angle Glaucoma; Primary Prevention; Publishing; Resources; Retinal; Retinal Ganglion Cells; Risk; Serum; Signal Transduction; Smoking; Smooth Muscle; Time; Trabecular meshwork structure; Translating; Variant; Vision; Visual Fields; Woman; Work; base; case control; cost effective; endophenotype; endothelial dysfunction; experience; follow-up; gene environment interaction; genetic variant; human NOS3 protein; improved; men; novel; optic nerve disorder; prospective; public health relevance

DESCRIPTION (provided by applicant): Primary open-angle glaucoma (POAG) is an intraocular pressure (IOP) - dependent, slowly progressive optic neuropathy that ultimately leads to blindness. Our prior work suggests that impaired nitric oxide (NO) signaling, exacerbated by declining estrogen levels contributes to dysfunctional endothelial cell - smooth muscle communication in POAG. In this proposal, using resources from the Nurses Health Study (NHS), we will compare circulating estrogen levels in postmenopausal women with and without POAG. Age at menopause has a genetic basis, and later age has been associated with reduced risk of POAG. Using data from the National Eye Institute Glaucoma Human Genetics Collaboration Heritable Overall Operational Database (NEIGHBORHOOD), we will evaluate whether a genetic predisposition score related to age at menopause is associated with POAG. Finally, we will also assess whether specific genotypes in the estrogen metabolic pathway interact with serum estrogen levels in POAG. Our data indicate that genomic variants in CAV1/CAV2, which codes for caveolins juxtaposed to NO synthase 3 (NOS3) in endothelial cell membranes, are related to POAG. Statin use may modulate the functional interaction between caveolin and NO signaling in endothelial cells to favorably alter glaucoma risk. We will perform a prospective cohort analysis of the relation between current statin use and POAG in NHS, NHS2 and the Health Professionals Follow-up Study (HPFS). We will also evaluate whether statin use interacts with common variants of CAV1/CAV2 and NOS3 in POAG. We will extend our analysis of environmental factors related to endothelial cell function to dietary bioflavonoids, which are known to alter endothelial cell function. There is evidence that POAG patients with initial paracentral visual field loss have endothelial cell dysfunction, yet little is known regarding environmental determinants of paracentral visual field loss in POAG. We have discovered two genetic biomarkers of endothelial cell dysfunction in POAG patients with paracentral visual field loss: CAV1/CAV2, GUCY1A3 / GUCY1B3. We will assess if factors that alter endothelial cell function, such as hypertension and postmenopausal hormone use, are associated with this glaucoma endophenotype. POAG is disease with a complex web of pathology. This proposal draws on the wealth of biomarkers related to endothelial cell dysfunction and estrogen metabolism in NHS, NHSII, HPFS and the NEIGHBORHOOD to dis- entangle that web. The proposal aims to identify and develop more rational preventive strategies and interventions for POAG.

描述（由申请人提供）：原发性开角型青光眼（POAG）是一种眼内压（IOP）依赖性、缓慢进行性视神经病变，最终导致失明。我们先前的工作表明，受损的一氧化氮（NO）信号传导，由雌激素水平下降加剧，导致POAG中内皮细胞-平滑肌通讯功能障碍。在这个建议中，我们将利用护士健康研究（NHS）的资源，比较绝经后POAG和非POAG妇女的循环雌激素水平。绝经年龄有遗传基础，年龄越大，POAG的风险越低。使用来自国家眼科研究所青光眼人类遗传协作遗传总体操作数据库（NEIGHBORHOOD）的数据，我们将评估与绝经年龄相关的遗传易感性评分是否与POAG相关。最后，我们还将评估雌激素代谢途径中的特定基因型是否与POAG的血清雌激素水平相互作用。我们的数据表明，CAV 1/CAV 2的基因组变异，其编码与内皮细胞膜中的NO合酶3（NOS 3）并列的小窝蛋白，与POAG有关。他汀类药物的使用可以调节内皮细胞中小窝蛋白和NO信号传导之间的功能性相互作用，从而有利地改变青光眼风险。我们将在NHS、NHS 2和卫生专业人员随访研究（HPFS）中对目前他汀类药物使用与POAG之间的关系进行前瞻性队列分析。我们还将评估他汀类药物的使用是否与POAG中常见的CAV 1/CAV 2和NOS 3变体相互作用。我们将扩展我们的分析环境因素相关的内皮细胞功能的饮食生物素，这是已知的改变内皮细胞功能。有证据表明，POAG患者的初始旁中心视野损失有内皮细胞功能障碍，但很少有人知道POAG的旁中心视野损失的环境决定因素。我们发现了两个POAG伴旁中心视野丧失患者内皮细胞功能障碍的遗传生物标志物：CAV 1/CAV 2，GUCY 1A 3/GUCY 1B 3。我们将评估改变内皮细胞功能的因素，如高血压和绝经后激素的使用，是否与这种青光眼内表型相关。原发性开角型青光眼是一种复杂的病理网络疾病。该建议利用NHS、NHSII、HPFS和NEIGHBORHOOD中与内皮细胞功能障碍和雌激素代谢相关的生物标志物来解开该网络。该提案旨在确定和制定更合理的POAG预防策略和干预措施。